[1. Dubljević V, Venero C, Knafo S. What is cognitive enhancement? In: Knafo S, Venero C, editors. Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors. Amsterdam: Elsevier Inc.; 2015. p. 1-9. doi: 10.1016/B978-0-12-417042-1.00001-210.1016/B978-0-12-417042-1.00001-2]Open DOISearch in Google Scholar
[2. Battleday RM, Brem A-K. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. Eur Neuropsychopharmacol 2015;25:1865-81. doi: 10.1016/j.euroneuro.2015.07.02810.1016/j.euroneuro.2015.07.02826381811]Open DOISearch in Google Scholar
[3. Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol Res 2010;62:187-206. doi: 10.1016/j.phrs.2010.04.00210.1016/j.phrs.2010.04.00220416377]Open DOISearch in Google Scholar
[4. Frati P, Kyriakou C, Rio A, Marinelli E, Vergallo G, Zaami S, Busardò FP. Smart drugs and synthetic androgens for cognitive and physical enhancement: revolving doors of cosmetic neurology. Curr Neuropharmacol 2015;13:5-11. doi: 10.2174/1570159X1366614121022175010.2174/1570159X13666141210221750446204326074739]Open DOISearch in Google Scholar
[5. Maslen H, Faulmüller N, Savulescu J. Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate. Front Syst Neurosci 2014;8:107. doi: 10.3389/fnsys.2014.0010710.3389/fnsys.2014.00107405273524999320]Search in Google Scholar
[6. Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci 2004;5:421-5. doi: 10.1038/nrn139010.1038/nrn139015100724]Open DOISearch in Google Scholar
[7. Massie CF, Yamga EM, Boot BP. Neuroenhancement: a call for better evidence on safety and efficacy. In: ter Meulen R, Mohammed A, Hall W, editors. Rethinking Cognitive Enhancement. Oxford: Oxford University Press; 2017. p. 57–68.10.1093/acprof:oso/9780198727392.003.0004]Search in Google Scholar
[8. Lengvenyte A, Strumila R, Grikiniene J. Use of cognitive enhancers among medical students in Lithuania. Nord Stud Alcohol Drugs 2016;33:173–88. doi:10.1515/nsad-2016-0014.10.1515/nsad-2016-0014]Search in Google Scholar
[9. Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD. Smart drugs “as common as coffee”: media hype about neuroenhancement. PLoS One 2011;6:e28416. doi: 10.1371/journal.pone.0028416.10.1371/journal.pone.0028416322766822140584]Open DOISearch in Google Scholar
[10. Benson K, Flory K, Humphreys KL, Lee SS. Misuse of stimulant medication among college students: A comprehensive review and meta-analysis. Clin Child Fam Psychol Rev 2015;18:50-76. doi: 10.1007/s10567-014-0177-z10.1007/s10567-014-0177-z25575768]Search in Google Scholar
[11. Nicholson PJ, Wilson N. Smart drugs: implications for general practice. Br J Gen Pract 2017;67:100-1. doi: 10.3399/bjgp17X68943710.3399/bjgp17X689437532562328232331]Open DOISearch in Google Scholar
[12. Weyandt LL, Oster DR, Marraccini ME, Gudmundsdottir BG, Munro BA, Rathkey ES, McCallum A. Prescription stimulant medication misuse: Where are we and where do we go from here? Exp Clin Psychopharmacol 2016;24:400-14. doi: 10.1037/pha000009310.1037/pha0000093511314127690507]Open DOISearch in Google Scholar
[13. Sharbaf Shoar N, Marwaha R, Molla M. Dextroamphetamine-Amphetamine. Treasure Island (FL): StatPearls Publishing; 2019.]Search in Google Scholar
[14. Verghese C, Abdijadid S. Methylphenidate. Treasure Island (FL): StatPearls Publishing; 2019.]Search in Google Scholar
[15. Greenblatt K, Adams N. Modafinil. Treasure Island (FL): StatPearls Publishing; 2019.]Search in Google Scholar
[16. Spencer RC, Devilbiss DM, Berridge CW. The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex. Biol Psychiatry 2015;77:940-50. doi: 10.1016/j.biopsych.2014.09.01310.1016/j.biopsych.2014.09.013437712125499957]Open DOISearch in Google Scholar
[17. Danielson ML, Bitsko RH, Ghandour RM, Holbrook JR, Kogan MD, Blumberg SJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child Adolesc Psychol 2018;47:199-212. doi: 10.1080/15374416.2017.141786010.1080/15374416.2017.1417860583439129363986]Open DOISearch in Google Scholar
[18. Bagot KS, Kaminer Y. Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review. Addiction 2014;109:547-57. PMCID: PMC447117310.1111/add.12460447117324749160]Search in Google Scholar
[19. Swanson JM, Wigal TL, Volkow ND. Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction: comment on Smith and Farah (2011). Psychol Bull 2011;137:742-8. doi: 10.1037/a002489810.1037/a0024898318762521859175]Search in Google Scholar
[20. The Guardian. Boseley S, Lignel B. Generation meds: the US children who grow up on prescription drugs [displayed 24 March 2019]. Available at https://www.theguardian.com/society/2015/nov/21/children-who-grow-up-on-prescription-drugs-us]Search in Google Scholar
[21. NewsComAu. Shepherd T. Childrens’ ADHD dexies turning parents into midnight runners. [displayed 24 March 2019]. Available at https://www.news.com.au/lifestyle/parenting/childrens-adhd-dexies-turning-parents-into-midnight-runners/news-story/9346cfddc1bb1b6c11cf0feeefe701fc?sv=7c00d6f8695c1520561030df513e3f03]Search in Google Scholar
[22. HuffPost Life. Samakow J. Prescription Drug Abuse: Report Calls Parent Pill Popping An “Epidemic” [displayed 24 March 2019]. Available at https://www.huffpost.com/entry/prescription-drug-abuse-parents_n_1515390]Search in Google Scholar
[23. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-23. doi: 10.1176/ajp.2006.163.4.71610.1176/ajp.2006.163.4.716285967816585449]Open DOISearch in Google Scholar
[24. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S. Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:21-31. doi: 10.1097/chi.0b013e31815a56f110.1097/chi.0b013e31815a56f118174822]Open DOISearch in Google Scholar
[25. Novak SP, Kroutil LA, Williams RL, Van Brunt DL. The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy 2007;2:32. doi: 10.1186/1747-597X-2-3210.1186/1747-597X-2-32221174717974020]Open DOISearch in Google Scholar
[26. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction 2007;102:740-51. doi:10.1111/j.1360-0443.2007.01758.x10.1111/j.1360-0443.2007.01758.x17506151]Open DOISearch in Google Scholar
[27. Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend 2006;84:135-43. doi: 10.1016/j.drugalcdep.2005.12.01110.1016/j.drugalcdep.2005.12.01116480836]Open DOISearch in Google Scholar
[28. South China Morning Post. Anonymous. PLA eyes “Night Eagle” to make army of night owls [displayed 25 March 2019]. Available at https://www.scmp.com/article/982075/pla-eyes-night-eagle-make-army-night-owls]Search in Google Scholar
[29. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008;456:702-5. doi: 10.1038/456702a10.1038/456702a19060880]Open DOISearch in Google Scholar
[30. Kim D. Practical use and risk of modafinil, a novel waking drug. Environ Health Toxicol 2012;27:e2012007. doi: 10.5620/eht.2012.27.e201200710.5620/eht.2012.27.e2012007328665722375280]Search in Google Scholar
[31. Sussman S, Pentz MA, Spruijt-Metz D, Miller T. Misuse of “study drugs:” prevalence, consequences, and implications for policy. Subst Abuse Treat Prev Policy 2006;1:15. doi: 10.1186/1747-597X-1-1510.1186/1747-597X-1-15152473516764722]Open DOISearch in Google Scholar
[32. Kudlow PA, Treurnicht Naylor K, Xie B, McIntyre RS. Cognitive enhancement in Canadian medical students. J Psychoactive Drugs 2013;45:360-5. doi: 10.1080/02791072.2013.8250332437717610.1080/02791072.2013.82503324377176]Search in Google Scholar
[33. McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005;100:96-106. doi: 10.1111/j.1360-0443.2005.00944.x10.1111/j.1360-0443.2005.00944.x1559819715598197]Open DOISearch in Google Scholar
[34. Emanuel RM, Frellsen SL, Kashima KJ, Sanguino SM, Sierles FS, Lazarus CJ. Cognitive enhancement drug use among future physicians: findings from a multi-institutional census of medical students. J Gen Intern Med 2013;28:1028-34. doi: 10.1007/s11606-012-2249-410.1007/s11606-012-2249-423595918371039423595918]Open DOISearch in Google Scholar
[35. Tuttle JP, Scheurich NE, Ranseen J. Prevalence of ADHD diagnosis and nonmedical prescription stimulant use in medical students. Acad Psychiatry 2010;34:220-3. doi: 10.1176/appi.ap.34.3.22010.1176/appi.ap.34.3.2202043110420431104]Open DOISearch in Google Scholar
[36. Webb JR, Valasek MA, North CS. Prevalence of stimulant use in a sample of US medical students. Ann Clin Psychiatry 2013;25:27-32. PMID: 23376867]Search in Google Scholar
[37. Graff Low K, Gendaszek AE. Illicit use of psychostimulants among college students: A preliminary study. Psychol Health Med 2002;7:283-7. doi: 10.1080/1354850022013938610.1080/13548500220139386]Open DOISearch in Google Scholar
[38. Barrett SP, Darredeau C, Bordy LE, Pihl RO. Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry 2005;50:457-61. doi: 10.1177/07067437050500080510.1177/07067437050500080516127963]Open DOISearch in Google Scholar
[39. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006;26:1501-10. doi: 10.1592/phco.26.10.150110.1592/phco.26.10.1501179422316999660]Search in Google Scholar
[40. Sattler S, Mehlkop G, Graeff P, Sauer C. Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics. Subst Abuse Treat Prev Policy 2014;9:8. doi: 10.1186/1747-597X-9-810.1186/1747-597X-9-8392862124484640]Search in Google Scholar
[41. Ilieva IP, Hook CJ, Farah MJ. Prescription stimulants’ effects on healthy inhibitory control, working memory, and episodic memory: a meta-analysis. J Cogn Neurosci 2015;27:1069-89. doi: 10.1162/jocn_a_0077610.1162/jocn_a_0077625591060]Open DOISearch in Google Scholar
[42. Smith ME, Farah MJ. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 2011;137:717-41. doi: 10.1037/a002382510.1037/a0023825359181421859174]Open DOISearch in Google Scholar
[43. McGaugh JL, Roozendaal B. Drug enhancement of memory consolidation: historical perspective and neurobiological implications. Psychopharmacology (Berl) 2009;202:3-14. doi: 10.1007/s00213-008-1285-610.1007/s00213-008-1285-618704369]Open DOISearch in Google Scholar
[44. Soetens E, Casaer S, D’Hooge R, Hueting JE. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology (Berl) 1995;119:155-62. doi: 10.1007/BF0224615610.1007/BF022461567659762]Open DOISearch in Google Scholar
[45. Marraccini ME, Weyandt LL, Rossi JS, Gudmundsdottir BG. Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration. Exp Clin Psychopharmacol 2016;24:269-84. doi: 10.1037/pha000007910.1037/pha0000079496888827454675]Open DOISearch in Google Scholar
[46. Ilieva IP, Farah MJ. Enhancement stimulants: perceived motivational and cognitive advantages. Front Neurosci 2013;7:198. doi: 10.3389/fnins.2013.0019810.3389/fnins.2013.00198381392424198755]Open DOISearch in Google Scholar
[47. Vrecko S. Just how cognitive is “Cognitive Enhancement”? On the significance of emotions in university students’ experiences with study drugs. AJOB Neurosci 2013;4:4-12. doi: 10.1080/21507740.2012.74014110.1080/21507740.2012.740141359064623486311]Open DOISearch in Google Scholar
[48. Cropsey KL, Schiavon S, Hendricks PS, Froelich M, Lentowicz I, Fargason R. Mixed-amphetamine salts expectancies among college students: Is stimulant induced cognitive enhancement a placebo effect? Drug Alcohol Depend 2017;178:302-9. doi: 10.1016/j.drugalcdep.2017.05.02410.1016/j.drugalcdep.2017.05.02428686989]Open DOISearch in Google Scholar
[49. Wood S, Sage JR, Shuman T, Anagnostaras SG. Psychostimulants and cognition: a continuum of behavioral and cognitive activation. Pharmacol Rev 2014;66:193-221. doi: 10.1124/pr.112.00705410.1124/pr.112.007054]Open DOISearch in Google Scholar
[50. Taylor SF, Welsh RC, Wager TD, Luan Phan K, Fitzgerald KD, Gehring WJ. A functional neuroimaging study of motivation and executive function. Neuroimage 2004;21:1045-54. doi: 10.1016/j.neuroimage.2003.10.03210.1016/j.neuroimage.2003.10.03215006672]Open DOISearch in Google Scholar
[51. Marshuetz C, Smith EE. Working memory for order information: Multiple cognitive and neural mechanisms. Neuroscience 2006;139:195-200. doi: 10.1016/j.neuroscience.2005.08.02410.1016/j.neuroscience.2005.08.024]Open DOISearch in Google Scholar
[52. Curtis CE. Prefrontal and parietal contributions to spatial working memory. Neuroscience 2006;139:173-80. doi: 10.1016/j.neuroscience.2005.04.07010.1016/j.neuroscience.2005.04.070]Open DOISearch in Google Scholar
[53. Nebel K, Wiese H, Stude P, de Greiff A, Diener H-C, Keidel M. On the neural basis of focused and divided attention. Cogn Brain Res 2005;25:760-76. doi: 10.1016/j.cogbrainres.2005.09.01110.1016/j.cogbrainres.2005.09.011]Open DOISearch in Google Scholar
[54. Rowe JB, Owen AM, Johnsrude IS, Passingham RE. Imaging the mental components of a planning task. Neuropsychologia 2001;39:315-27. doi: 10.1016/S0028-3932(00)00109-310.1016/S0028-3932(00)00109-3]Open DOISearch in Google Scholar
[55. Yerkes RM, Dodson JD. The relation of strength of stimulus to rapidity of habit-formation. J Comp Neurol Psychol 1908;18:459–82. doi: 10.1002/cne.920180503.10.1002/cne.920180503]Open DOISearch in Google Scholar
[56. Yerkes RM. Modifiability of behavior in its relations to the age and sex of the dancing mouse. J Comp Neurol Psychol 1909;19:237-71. doi: 10.1002/cne.92019030310.1002/cne.920190303]Open DOISearch in Google Scholar
[57. Dodson JD. The relation of strength of stimulus to rapidity of habit-formation in the kitten. J Anim Behav 1915;5:330-6. doi: 10.1037/h007341510.1037/h0073415]Open DOISearch in Google Scholar
[58. Chaby LE, Sheriff MJ, Hirrlinger AM, Braithwaite VA. Can we understand how developmental stress enhances performance under future threat with the Yerkes-Dodson law? Commun Integr Biol 2015;8:e1029689. doi: 10.1080/19420889.2015.102968910.1080/19420889.2015.1029689459436926479861]Search in Google Scholar
[59. Broadhurst PL. Emotionality and the Yerkes-Dodson law. J Exp Psychol 1957;54:345-52. doi: 10.1037/h004911410.1037/h0049114]Open DOISearch in Google Scholar
[60. Salehi B, Cordero MI, Sandi C. Learning under stress: the inverted-U-shape function revisited. Learn Mem 2010;17:522-30. doi: 10.1101/lm.191411010.1101/lm.191411020884754]Open DOISearch in Google Scholar
[61. Diamond DM, Campbell AM, Park CR, Halonen J, Zoladz PR. The temporal dynamics model of emotional memory processing: a synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes-Dodson law. Neural Plast 2007;2007:60803. doi: 10.1155/2007/6080310.1155/2007/60803]Search in Google Scholar
[62. Pribram KH, McGuinness D. Arousal, activation, and effort in the control of attention. Psychol Rev 1975;82:116-49. doi: 10.1037/h007678010.1037/h0076780]Open DOISearch in Google Scholar
[63. Lafreniere KD. Reversal theory: an introduction. Patient Educ Couns 1993;22:63-71. doi: 10.1016/0738-3991(93)90002-E10.1016/0738-3991(93)90002-]Open DOISearch in Google Scholar
[64. Martin RA, Kuiper NA, Olinger LJ, Dobbin J. Is stress always bad? Telic versus paratelic dominance as a stress-moderating variable. J Pers Soc Psychol 1987;53:970-82. doi: 10.1037/0022-3514.53.5.97010.1037/0022-3514.53.5.970]Open DOISearch in Google Scholar
[65. Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 1997;68:2032-7. doi: 10.1046/j.1471-4159.1997.68052032.x10.1046/j.1471-4159.1997.68052032.x9109529]Open DOISearch in Google Scholar
[66. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AFT, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006;60:1111-20. doi: 10.1016/j.biopsych.2006.04.02210.1016/j.biopsych.2006.04.02216806100]Search in Google Scholar
[67. Schmeichel BE, Berridge CW. Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants. Neuropsychopharmacology 2013;38:1078-84. doi: 10.1038/npp.2013.610.1038/npp.2013.6362940723303075]Open DOISearch in Google Scholar
[68. Wood SC, Anagnostaras SG. Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice. Psychopharmacology (Berl) 2009;202:197-206. doi: 10.1007/s00213-008-1185-910.1007/s00213-008-1185-9288419518478205]Open DOISearch in Google Scholar
[69. Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 2006;319:561-9. doi: 10.1124/jpet.106.10658310.1124/jpet.106.106583]Open DOISearch in Google Scholar
[70. Ferraro L, Fuxe K, Tanganelli S, Fernandez M, Rambert FA, Antonelli T. Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil. Neuropharmacology 2000;39:1974-83. doi: 10.1016/s0028-3908(00)00019-810.1016/s0028-3908(00)00019-8]Open DOISearch in Google Scholar
[71. Huang Q, Zhang L, Tang H, Wang L, Wang Y. Modafinil modulates GABA-activated currents in rat hippocampal pyramidal neurons. Brain Res 2008;1208:74-8. doi: 10.1016/j.brainres.2008.02.02410.1016/j.brainres.2008.02.02418395702]Search in Google Scholar
[72. Haris M, Singh A, Cai K, Nath K, Verma G, Nanga RPR, Hariharan H, Detre JA, Epperson N, Reddy R. High resolution mapping of modafinil induced changes in glutamate level in rat brain. PLoS One 2014;9:e103154. doi: 10.1371/journal.pone.010315410.1371/journal.pone.0103154411338225068408]Search in Google Scholar
[73. Ishizuka T, Murotani T, Yamatodani A. Modanifil activates the histaminergic system through the orexinergic neurons. Neurosci Lett 2010;483:193–6. doi: 10.1016/j.neulet.2010.08.00510.1016/j.neulet.2010.08.00520696213]Open DOISearch in Google Scholar
[74. Mereu M, Chun LE, Prisinzano T, Newman AH, Katz JL, Tanda G. The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice. Eur J Neurosci 2017;45:167-74. doi: 10.1111/ejn.133762754528510.1111/ejn.13376560433727545285]Search in Google Scholar
[75. Repantis D, Maier LJ, Heuser I. Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects. Eur Neuropsychopharmacol 2016;26:392-3. doi: 10.1016/j.euroneuro.2015.12.0162670669510.1016/j.euroneuro.2015.12.01626706695]Search in Google Scholar
[76. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology (Berl) 2002;159:238-47. doi: 10.1007/s00213010091610.1007/s00213010091611862356]Open DOISearch in Google Scholar
[77. Wesensten NJ, Killgore WDS, Balkin TJ. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res 2005;14:255-66. doi: 10.1111/j.1365-2869.2005.00468.x10.1111/j.1365-2869.2005.00468.x16120100]Open DOISearch in Google Scholar
[78. Franke AG, Gränsmark P, Agricola A, Schühle K, Rommel T, Sebastian A, Balló HE, Gorbulev S, Gerdes C, Frank B, Ruckes C, Tüscher O, Lieb K. Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial. Eur Neuropsychopharmacol 2017;27:248-60. doi: 10.1016/j.euroneuro.2017.01.0062811908310.1016/j.euroneuro.2017.01.00628119083]Search in Google Scholar
[79. Myrick H, Malcolm R, Taylor B, LaRowe S. Modafinil: preclinical, clinical, and post-marketing surveillance - a review of abuse liability issues. Ann Clin Psychiatry 2004;16:101-9. doi: 10.1080/1040123049045374310.1080/104012304904537431532890315328903]Open DOISearch in Google Scholar
[80. Malcolm R, Book SW, Moak D, DeVane L, Czepowicz V. Clinical applications of modafinil in stimulant abusers: low abuse potential. Am J Addict 2002;11:247-9. doi: 10.1080/1055049029008802710.1080/1055049029008802712202017]Open DOISearch in Google Scholar
[81. Warot D, Corruble E, Payan C, Weil JS, Puech AJ. Subjective effects of modafinil, a new central adrenergic stimulant in healthy volunteers: a comparison with amphetamine, caffeine and placebo. Eur Psychiatry 1993;8:201-8.10.1017/S0924933800002923]Search in Google Scholar
[82. Cope ZA, Minassian A, Kreitner D, MacQueen DA, Milienne-Petiot M, Geyer MA, Perry W, Young JW. Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species. Neuropharmacology 2017;125:254-62. doi: 10.1016/j.neuropharm.2017.07.03110.1016/j.neuropharm.2017.07.031647290228774856]Open DOISearch in Google Scholar
[83. Ozturk A, Deveci E. Drug abuse of modafinil by a cannabis user. Klin Psikofarmakol Bülteni - Bulletin Clin Psychopharmacol 2014;24:405-7. doi: 10.5455/bcp.2013062401330310.5455/bcp.20130624013303]Open DOISearch in Google Scholar
[84. Krishnan R, Chary KV. A rare case modafinil dependence. J Pharmacol Pharmacother 2015;6:49-50. doi: 10.4103/0976-500X.14914910.4103/0976-500X.149149431925225709356]Open DOISearch in Google Scholar
[85. Schmidt A, Müller F, Dolder PC, Schmid Y, Zanchi D, Egloff L, Liechti ME, Borgwardt S. Acute effects of methylphenidate, modafinil, and MDMA on negative emotion processing. Int J Neuropsychopharmacol 2018;21:345-54. doi: 10.1093/ijnp/pyx11210.1093/ijnp/pyx112588741429206921]Open DOISearch in Google Scholar
[86. Kampman KM, Lynch KG, Pettinati HM, Spratt K, Wierzbicki MR, Dackis C, O’Brien CP. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug Alcohol Depend 2015;155:105-10. doi: 10.1016/j.drugalcdep.2015.08.00510.1016/j.drugalcdep.2015.08.005458200326320827]Search in Google Scholar
[87. Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Chang LC, Newton TF. Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers. Int J Neuropsychopharmacol 2012;15:1241-9. doi: 10.1017/S146114571100180510.1017/S1461145711001805341189622214752]Open DOISearch in Google Scholar
[88. Ghahremani DG, Tabibnia G, Monterosso J, Hellemann G, Poldrack RA, London ED. Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals. Neuropsychopharmacology 2011;36:950-9. doi: 10.1038/npp.2010.23310.1038/npp.2010.233307726421289606]Open DOISearch in Google Scholar
[89. Hatori M, Gronfier C, Van Gelder RN, Bernstein PS, Carreras J, Panda S, Marks F, Sliney D, Hunt CE, Hirota T, Furukawa T, Tsubota K. Global rise of potential health hazards caused by blue light-induced circadian disruption in modern aging societies. NPJ Aging Mech Dis 2017;3:9. doi: 10.1038/s41514-017-0010-210.1038/s41514-017-0010-2547380928649427]Open DOISearch in Google Scholar
[90. Medic G, Wille M, Hemels ME. Short- and long-term health consequences of sleep disruption. Nat Sci Sleep 2017;9:151-61. doi: 10.2147/NSS.S13486410.2147/NSS.S134864544913028579842]Open DOISearch in Google Scholar